Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

Historical Holders from Q3 2014 to Q1 2025

Symbol
AUPH on Nasdaq
CUSIP
05156V102
Type / Class
Equity / Common Shares, no par value
Shares outstanding
137M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
57.7M
Holdings value
$518M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
198
Number of buys
94
Number of sells
-65
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TANG CAPITAL MANAGEMENT LLC 7.3% $81.7M 10M TANG CAPITAL MANAGEMENT, LLC Feb 28, 2025
ARMISTICE CAPITAL, LLC 4.47% $52.2M 6.4M Armistice Capital, LLC Dec 31, 2024

Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 399K $3.2M +$13.5K $8.04 16
2024 Q4 57.7M $518M +$4.09M $8.98 198
2024 Q3 57.6M $422M +$21.8M $7.33 181
2024 Q2 55.3M $316M +$5.66M $5.71 169
2024 Q1 54.6M $273M +$4.06M $5.01 173
2023 Q4 53.2M $478M +$39.8M $8.99 183
2023 Q3 50.2M $390M -$989K $7.77 191
2023 Q2 49.7M $481M -$2.67M $9.68 194
2023 Q1 50M $548M +$7.32M $10.96 180
2022 Q4 51.1M $221M -$24.3M $4.32 179
2022 Q3 49.9M $375M +$26.7M $7.52 170
2022 Q2 49.6M $498M +$69.9M $10.05 187
2022 Q1 41.6M $515M +$963K $12.38 172
2021 Q4 38.4M $879M -$113M $22.87 175
2021 Q3 43M $952M -$4.44M $22.13 156
2021 Q2 49.1M $636M -$41.9M $12.96 160
2021 Q1 52.1M $677M -$80.7M $12.99 161
2020 Q4 56.9M $787M -$114M $13.83 135
2020 Q3 64.7M $953M +$74.7M $14.73 141
2020 Q2 58.6M $952M -$25.1M $16.25 124
2020 Q1 60.2M $874M +$158M $14.51 120
2019 Q4 48.8M $989M +$508M $20.26 108
2019 Q3 25.5M $136M -$23.3M $5.34 66
2019 Q2 29.3M $193M -$3.02M $6.58 68
2019 Q1 29.6M $193M +$49M $6.50 73
2018 Q4 22.2M $151M +$5.11M $6.82 56
2018 Q3 21.4M $142M +$1.97M $6.64 57
2018 Q2 21.3M $120M -$2.4M $5.63 62
2018 Q1 21.7M $113M -$10M $5.19 59
2017 Q4 23.1M $105M -$3.68M $4.53 62
2017 Q3 23.4M $147M +$1.99M $6.27 57
2017 Q2 23.2M $142M -$6.91M $6.13 63
2017 Q1 23.4M $170M +$109M $7.34 69
2016 Q4 8.62M $18.1M +$8.66M $2.10 21
2016 Q3 4.24M $12.8M -$8.13M $3.01 14
2016 Q2 7.07M $20.1M +$875K $2.78 12
2016 Q1 6.74M $19.7M +$25K $2.92 16
2015 Q4 6.73M $16.8M -$1.11M $2.47 14
2015 Q3 7.11M $20.1M +$2.91M $2.84 11
2015 Q2 7.21M $21.7M -$251K $3.02 10
2015 Q1 6.1M $26.7M +$445K $4.37 9
2014 Q4 12.7K $47K +$1K $4.76 2
2014 Q3 6.02M $19.3M +$19.3M $3.20 8